Phytopharmaceutical practices of traditional health practitioners in Burkina Faso: a cross-sectional study.
Burkina Faso
Medicinal plants
Phytopharmaceutical practices
Traditional health practitioners
Traditional medicines
Journal
BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232
Informations de publication
Date de publication:
30 Jun 2023
30 Jun 2023
Historique:
received:
06
01
2023
accepted:
25
06
2023
medline:
3
7
2023
pubmed:
1
7
2023
entrez:
30
6
2023
Statut:
epublish
Résumé
Traditional health practitioners constitute an important part of the health care system in Burkina Faso, particularly in the supply of traditional herbal medicines. Quality and safety of these medicines rely heavily on practices employed during their traditional development. However, traditional phytopharmaceutical practices are poorly described in Burkina Faso. This study aimed to describe the phytopharmaceutical practices of traditional medicine practitioners in Burkina Faso. This was a cross-sectional descriptive ethno-pharmaceutical study, conducted from October 1 to November 30, 2020, among traditional practitioners in four randomly selected health districts: Nongr-Massom (Centre region), Tenkodogo (Centre-East region), Diapaga (East region) and Dafra (Hauts-Bassins region). An anonymous semi-structured face-to-face questionnaire was used to collect socio-demographic data and data on raw materials and finished products. Sixty-seven (67) traditional health practitioners, aged 56 years on average, including a majority of men (72%), participated in the study. Gathering of wild medicinal plants was the main source of raw materials acquisition (51.5%), which were usually leaves (32.3%). These raw materials were usually sun-dried (43.9%) and packaged mostly in plastic bags (37.2%). They were derived from 60 plant species belonging to 33 botanical families. Fabaceae was the most represented family (18.7%) and Khaya senegalensis Juss. (Meliaceae) the most cited plant species (5.2%). The finished products had an average shelf life of 17 months and were usually prepared as a decoction (31.7%) and administered most often orally (71.4%). Gastrointestinal disorders were the main predictable adverse events of the finished products (54%). This study showed that THPs have important knowledge in the use of medicinal plants, but several shortcomings are observed in their phytopharmaceutical and plant protection practices. Continuous improvement of these practices, through education and training of traditional health practitioners, is essential for the conservation of plant biodiversity and quality assurance of traditional herbal medicines.
Sections du résumé
BACKGROUND
BACKGROUND
Traditional health practitioners constitute an important part of the health care system in Burkina Faso, particularly in the supply of traditional herbal medicines. Quality and safety of these medicines rely heavily on practices employed during their traditional development. However, traditional phytopharmaceutical practices are poorly described in Burkina Faso. This study aimed to describe the phytopharmaceutical practices of traditional medicine practitioners in Burkina Faso.
METHODS
METHODS
This was a cross-sectional descriptive ethno-pharmaceutical study, conducted from October 1 to November 30, 2020, among traditional practitioners in four randomly selected health districts: Nongr-Massom (Centre region), Tenkodogo (Centre-East region), Diapaga (East region) and Dafra (Hauts-Bassins region). An anonymous semi-structured face-to-face questionnaire was used to collect socio-demographic data and data on raw materials and finished products.
RESULTS
RESULTS
Sixty-seven (67) traditional health practitioners, aged 56 years on average, including a majority of men (72%), participated in the study. Gathering of wild medicinal plants was the main source of raw materials acquisition (51.5%), which were usually leaves (32.3%). These raw materials were usually sun-dried (43.9%) and packaged mostly in plastic bags (37.2%). They were derived from 60 plant species belonging to 33 botanical families. Fabaceae was the most represented family (18.7%) and Khaya senegalensis Juss. (Meliaceae) the most cited plant species (5.2%). The finished products had an average shelf life of 17 months and were usually prepared as a decoction (31.7%) and administered most often orally (71.4%). Gastrointestinal disorders were the main predictable adverse events of the finished products (54%).
CONCLUSION
CONCLUSIONS
This study showed that THPs have important knowledge in the use of medicinal plants, but several shortcomings are observed in their phytopharmaceutical and plant protection practices. Continuous improvement of these practices, through education and training of traditional health practitioners, is essential for the conservation of plant biodiversity and quality assurance of traditional herbal medicines.
Identifiants
pubmed: 37391813
doi: 10.1186/s12906-023-04055-z
pii: 10.1186/s12906-023-04055-z
pmc: PMC10311739
doi:
Substances chimiques
Plant Extracts
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
215Subventions
Organisme : Fondation Pierre Fabre
ID : doctoral scholarship provided to Kampadilemba Ouoba
Informations de copyright
© 2023. The Author(s).
Références
Evid Based Complement Alternat Med. 2018 Nov 08;2018:1035875
pubmed: 30532793
BMC Complement Altern Med. 2017 Nov 14;17(1):489
pubmed: 29137614
Curationis. 2015 Jul 23;38(2):1495
pubmed: 26244463
Chin Herb Med. 2021 Sep 27;13(4):472-479
pubmed: 36119364
Women Health. 2018 May-Jun;58(5):598-615
pubmed: 28430032
BMJ Glob Health. 2019 Oct 11;4(Suppl 9):e001517
pubmed: 31673437
J Ethnopharmacol. 1984 Jun;11(1):33-47
pubmed: 6471880
J Ethnopharmacol. 2010 Jun 16;129(3):367-76
pubmed: 20382213
Glob Health Action. 2020 Dec 31;13(1):1838241
pubmed: 33150856
J Ethnopharmacol. 2014 Aug 8;155(1):580-8
pubmed: 24928824
BMC Complement Altern Med. 2016 Mar 15;16:102
pubmed: 26980526
J Ethnopharmacol. 2020 Oct 5;260:112662
pubmed: 32147477
Eur J Clin Pharmacol. 2016 May;72(5):623-30
pubmed: 26895223
J Ethnopharmacol. 2011 Jan 27;133(2):378-95
pubmed: 20950680
Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):115-23
pubmed: 22754064
BMJ. 2008 Mar 8;336(7643):536-8
pubmed: 18325964
Public Health. 2018 Dec;165:1-5
pubmed: 30326344
J Ethnopharmacol. 2004 Dec;95(2-3):113-21
pubmed: 15507322
Sci Rep. 2021 Nov 2;11(1):21476
pubmed: 34728662
J Ethnopharmacol. 2011 Jan 7;133(1):234-43
pubmed: 20932887
J Ethnopharmacol. 2020 Jan 10;246:112205
pubmed: 31476442
Eur J Pharm Sci. 2021 Jul 1;162:105812
pubmed: 33753215
BMJ Open. 2020 Sep 10;10(9):e040769
pubmed: 32912997
Pharm Biol. 2012 Jul;50(7):807-15
pubmed: 22471920